Tower Research Capital LLC (Trc) Lucid Diagnostics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,169 shares of LUCD stock, worth $8,961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,169
Previous 6,067
18.16%
Holding current value
$8,961
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LUCD
# of Institutions
37Shares Held
3.87MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX1.02MShares$1.27 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$701,1430.0% of portfolio
-
Sargent Investment Group, LLC542KShares$676,8750.07% of portfolio
-
Sunbelt Securities, Inc. Houston, TX384KShares$479,9980.06% of portfolio
-
Geode Capital Management, LLC Boston, MA280KShares$349,3800.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $48.2M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...